DiaMedica Therapeutics Inc. (DMAC)

DiaMedica Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.33	3.03	4.54	4.73	4.71	7.41
Short-Term Investments	51.99	41.12	48.35	28.77	40.41	20.1
Cash & Short-Term Investments	55.32	44.15	52.9	33.5	45.11	27.51
Cash Growth	10.20%	-16.54%	57.89%	-25.74%	64.00%	249.16%
Accounts Receivable	0.26	0.24	0.37	0.08	0.13	0.34
Other Current Assets	0.65	0.23	0.41	0.25	0.2	0.07
Total Current Assets	56.22	44.61	53.68	33.84	45.44	27.92
Net Property, Plant & Equipment	0.37	0.43	0.49	0.56	0.11	0.17
Other Long-Term Assets	0.46	1.31	-	-	-	-
Total Assets	57.05	46.35	54.16	34.4	45.55	28.1
Accounts Payable	1.82	0.94	0.93	0.73	0.51	1.1
Accrued Expenses	3.34	4.35	1.78	1.37	0.97	0.86
Current Portion of Leases	0.11	0.1	0.08	0.07	0.05	0.07
Total Current Liabilities	5.27	5.39	2.79	2.17	1.52	2.03
Long-Term Leases	0.16	0.24	0.32	0.4	0	0.05
Total Long-Term Liabilities	0.16	0.24	0.32	0.4	0	0.05
Total Liabilities	5.43	5.63	3.1	2.57	1.53	2.08
Additional Paid-in Capital	215.61	180.7	166.61	128.08	126.58	94.93
Accumulated Other Comprehensive Income	0.05	0.02	0.01	-0.07	-0.05	-0
Retained Earnings	-164.03	-140	-115.56	-96.18	-82.5	-68.91
Shareholders' Equity	51.62	40.72	51.06	31.83	44.02	26.01
Total Liabilities & Equity	57.05	46.35	54.16	34.4	45.55	28.1
Total Debt	0.27	0.34	0.4	0.47	0.05	0.12
Net Cash (Debt)	55.05	43.81	52.5	33.03	45.06	27.39
Net Cash Growth	25.67%	-16.55%	58.92%	-26.69%	64.52%	255.70%
Net Cash Per Share	1.24	1.08	1.61	1.25	2.17	1.75
Book Value	51.62	40.72	51.06	31.83	44.02	26.01
Book Value Per Share	1.16	1.01	1.57	1.20	2.12	1.66
Tangible Book Value	51.62	40.72	51.06	31.83	44.02	26.01
Tangible Book Value Per Share	1.16	1.01	1.57	1.20	2.12	1.66

Updated Nov 12, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q